Claritas Pharmaceuticals, Inc. (CLAZF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Apr 1, 2025
Claritas Pharmaceuticals Statistics
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
CLAZF has 37.79 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 37.79M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +6.00% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
The trailing PE ratio is 0.00.
PE Ratio | 0.00 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 0.00 |
P/TBV Ratio | 0.00 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.16.
Current Ratio | 1.42 |
Quick Ratio | 0.01 |
Debt / Equity | 0.16 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 0.17 |
Financial Efficiency
Return on equity (ROE) is 65.09% and return on invested capital (ROIC) is 8.69%.
Return on Equity (ROE) | 65.09% |
Return on Assets (ROA) | 2.77% |
Return on Invested Capital (ROIC) | 8.69% |
Return on Capital Employed (ROCE) | 14.74% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | 22.44 |
52-Week Price Change | n/a |
50-Day Moving Average | 0.00 |
200-Day Moving Average | 0.04 |
Relative Strength Index (RSI) | 45.58 |
Average Volume (20 Days) | 3,144 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | 485,000 |
Pretax Income | -3.08M |
Net Income | -4.72M |
EBITDA | n/a |
EBIT | 485,000 |
Earnings Per Share (EPS) | -0.13 |
Balance Sheet
The company has 2,000 in cash and 538,000 in debt, giving a net cash position of -536,000 or -0.01 per share.
Cash & Cash Equivalents | 2,000 |
Total Debt | 538,000 |
Net Cash | -536,000 |
Net Cash Per Share | -0.01 |
Equity (Book Value) | 3.28M |
Book Value Per Share | 0.09 |
Working Capital | 3.28M |
Cash Flow
Operating Cash Flow | -953,000 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CLAZF does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -33.44% |
Shareholder Yield | -33.44% |
Earnings Yield | -12,415,789.47% |
FCF Yield | n/a |
Stock Splits
The last stock split was on July 23, 2021. It was a reverse split with a ratio of 0.05.
Last Split Date | Jul 23, 2021 |
Split Type | Reverse |
Split Ratio | 0.05 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |